Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Pharmacist unable to prevent Costa allergy death due to EpiPen shortage

A pharmacist was unable to save a girl who died from a severe allergic reaction to a Costa Coffee drink “due to a national shortage of adrenaline auto injectors”, a coroner has found. 

After a severe allergic reaction to a hot chocolate, a “national shortage” of EpiPens meant that a pharmacist could not prevent the death of 13-year-old Hannah Eniola Angela Ayomipo Jacobs, a coroner has found.

In a report published last week (August 30), coroner Dr Shirley Radcliffe said that Jacobs was “incorrectly” served a “dairy hot chocolate at Costa Coffee Barking despite her mother informing staff of a dairy allergy” on her way to a dentist appointment on February 8 2023.

The report said that when the pair arrived at the dentist, Jacobs “took a sip of her drink and felt unwell”.

Jacobs had “severe allergies to eggs, dairy and wheat” but “neither she nor her mother were carrying an adrenaline auto injector that had been prescribed”, it added.

She “refused treatment and left the dentist with her mother to go to a local pharmacy for treatment”, the report said.

Jacobs and her mother “rushed to the Day Night Pharmacy where [she] collapsed” before she “sadly…went into cardiac arrest and could not be resuscitated,” it added.

 

“Insufficient dosage”

 

In a second report also published last week, the coroner said that when Jacobs entered the pharmacy “her mother asked for cetirizine that had previously helped” but “it was given to no effect”.

“An EpiPen was requested but due to a national shortage of adrenaline auto injectors, the pharmacist had only one paediatric injector that was of an insufficient dosage,” she added.

The “only one in stock” was “150 micrograms rather than the 500 [Jacobs] had been prescribed”, Radcliffe said.

“I was made aware there had been a shortage of adrenaline auto injectors at the time, but a vial of adrenaline was available at the chemist,” she added.

“However, it takes time to draw up,” she said.

“I am not sure whether – assuming no national shortage – all chemists have adrenaline auto injectors in stock for emergencies,” she added.

 

“Action should be taken” 

 

Radcliffe found that there is “a risk that future deaths could occur unless action is taken”.

She sent her findings to health secretary Wes Streeting, NHS England’s (NHSE) national medical director and chief executive of the General Pharmaceutical Council (GPhC) Duncan Rudkin, among various others.

She stressed that “action should be taken” by the organisations and instructed them to reply “within 56 days of the date of this report, namely by October 15”.

The Department of Health and Social Care (DH) told C+D today that its “deepest sympathies are with the family and friends of Hannah Jacobs and all those impacted by this case”.

"We have been in ongoing discussions with the Natasha Allergy Research Foundation about improving support for people with allergies,” it added.

“Ministers will carefully consider their views and any recommendations made by the coroner following the tragic death of Hannah Jacobs,” it said.

Read more: Opinion: The DH needs to act on allergies after latest death

A GPhC spokesperson told C+D that it too is "currently carefully reviewing this prevention of future deaths report".

And NHSE also said that it "extends its deepest sympathies to the family and friends of Hannah Jacobs", is "carefully considering" the report and "will respond in due course”.

C+D also approached Costa Coffee and the pharmacy for comment.

Related Content

Topics

         
Registrant member of the Assurance and Appointments Committee 
Nationwide
£ Renumeration

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD138474

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel